PedAM
Pediatric Disease Annotations & Medicines
| Disease | lung cancer |
| Phenotype | C0011860|type 2 diabetes |
| Sentences | 9 |
| PubMedID- 23431102 | The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. |
| PubMedID- 22923670 | Metformin use is not associated with a decreased risk of lung cancer in patients with type 2 diabetes. |
| PubMedID- 25144301 | Epidemiological studies report higher lung cancer mortality rates in patients with type 2 diabetes. |
| PubMedID- 24236069 | We excluded those who had diagnosis of systemic lupus erythematosus (sle), human immunodeficiency virus (hiv) infection, and lung cancer in patients with type 2 diabetes and control subjects. |
| PubMedID- 24289561 | Expression characteristics of proteins of the insulin-like growth factor axis in non-small cell lung cancer patients with preexisting type 2 diabetes mellitus. |
| PubMedID- 21523768 | Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes. |
| PubMedID- 23431103 | The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. |
| PubMedID- 24051132 | Examining the association between statins and lung cancer incidence in patients with type 2 diabetes mellitus. |
| PubMedID- 26459254 | Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis. |
Page: 1